Program in Evidence-based Care
Systemic treatment of acute myeloid leukemia (AML).
|Schuh AC, Fletcher GG, Leber B, Sabloff M, members of the Hematology Disease Site Group. Systemic treatment of acute myeloid leukemia (AML). Toronto (ON): Cancer Care Ontario (CCO); 2016 Feb 2. 245 p. (Program in Evidence-based Care (PEBC) Guideline; no. 12-9). [393 references]|
This is the current release of the guideline.
The Program in Evidence-based Care (PEBC) Guideline over time will expand to contain new information emerging from their reviewing and updating activities.
Please visit the Cancer Care Ontario (CCO) Web site for details on any new evidence that has emerged and implications to the guidelines.
This guideline meets NGC's 2013 (revised) inclusion criteria.